# Assembly Biosciences (ASMB) — Analyst Forecast

ASMB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/asmb/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 0 | 5 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $45.00 | $49.00 | $52.00 | 3 |

Last price $20.57 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 1, 2026 | Mizuho | Maintained | Outperform | $45.00 |
| Sep 1, 2026 | UBS | Initiated Coverage | Buy | $52.00 |
| Aug 18, 2026 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| Jun 15, 2026 | Mizuho | Maintained | Outperform | $45.00 |
| May 28, 2026 | Guggenheim | Maintained | Buy | $43.00 |
| May 4, 2026 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| Apr 6, 2026 | Guggenheim | Maintained | Buy | $43.00 |
| Mar 26, 2026 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| Dec 22, 2025 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| Nov 20, 2025 | Mizuho | Maintained | Outperform | $40.00 |
| Oct 14, 2025 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| Sep 24, 2025 | JMP Securities | Initiated Coverage | Market Outperform | $38.00 |
| Sep 8, 2025 | Guggenheim | Maintained | Buy | $39.00 |
| Aug 18, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $50.00 |
| Mar 25, 2025 | Guggenheim | Initiated Coverage | Buy | $31.00 |
| Mar 24, 2025 | HC Wainwright & Co. | Maintained | Neutral | — |
| Dec 27, 2024 | HC Wainwright & Co. | Maintained | Neutral | — |
| Sep 24, 2024 | HC Wainwright & Co. | Maintained | Neutral | — |
| Sep 20, 2024 | Jefferies | Upgraded | Hold → Buy | $35.00 |
| Jun 20, 2024 | HC Wainwright & Co. | Maintained | Neutral | — |

## Frequently Asked Questions

### What is the price target for ASMB stock?

The average 12-month analyst price target for Assembly Biosciences (ASMB) is $49.00, with a high estimate of $52.00 and a low of $45.00, across 3 analysts.

### Is ASMB a buy, sell, or hold?

Analysts covering Assembly Biosciences currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ASMB?

The average price target of $49.00 implies 138.21% upside from the last price of $20.57.

### What is the latest analyst rating on ASMB?

On Sep 1, 2026, Mizuho maintained Assembly Biosciences at Outperform with a price target of $45.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).